Epic Update : Lupin Pharmaceuticals

Lupin Pharmaceuticals Inc (collectively Lupin) has received final approval for its Levonorgestrel and Ethinyl Estradiol tablets USP, 0.1 mg / 0.02 mg from the United States Food and Drugs Administration (USFDA) to market a generic version of Watson Laboratories, Inc.’s Lutera 28 tablets. As per IMS MAT Sept 2012 sales, Lutera tablets had annual US sales of approximately $103.6 million.

Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.